Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2036 participants.
Also called NCT03620760
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,036 participants
- Sponsor
- Xiaofan Wu
- Registry
-
NCT03620760
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03620760. Randomized; no masking; primary purpose treatment. Start 2018-08-07 (actual); primary completion 2020-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation
- Condition
- Unstable Angina Pectoris
- Condition
- Coronary Stent Implantation
- Intervention (Drug)
- Ticagrelor 90 mg
- Intervention (Drug)
- Ticagrelor 45 mg
- Intervention (Drug)
- Aspirin
- Lead sponsor
- Xiaofan Wu
Record details
- Record id
cardio:ct-nct03620760- Content hash
f44b7fe29b014ee37c695b5e3afa9b65d58018859ee1dc669d1fc9948f0b0b7b